Gentibio, Inc.

Cambridge, MA

UEI
HNHTFLZ9U5D4
CAGE
9YYH9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
150 Cambridgepark Dr Suite 900, Cambridge, MA 02140, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Gentibio, Inc.'s 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Gnti-148: an allogeneic islet-specific engineered treg for treating T1D - abstract type 1 diabetes (T1D) is a chronic… Grant · R44DK148168 National Institute of Diabetes and Digestive and Kidney Diseases $1,066,332
Tissue-engineered tregs for the treatment of amyotrophic lateral sclerosis Grant · HT9425261E077 Defense Health Agency $825,756
Development of tissue engineered tregs as a treatment for acute ischemic stroke - abstract in the u.s., nearly 800,000… Grant · R44NS145848 National Institute of Neurological Disorders and Stroke $2,301,166

Quick answers

What is Gentibio, Inc.'s UEI?

Gentibio, Inc.'s Unique Entity ID (UEI) in SAM.gov is HNHTFLZ9U5D4.

What is Gentibio, Inc.'s CAGE code?

Gentibio, Inc.'s CAGE code is 9YYH9.

What is Gentibio, Inc.'s primary NAICS code?

Gentibio, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Gentibio, Inc. located?

Gentibio, Inc.'s physical address in SAM.gov is 150 Cambridgepark Dr Suite 900, Cambridge, MA 02140, USA.

Is Gentibio, Inc. registered in SAM.gov?

Yes. Gentibio, Inc.'s SAM.gov registration is active through May 30, 2027.

What is Gentibio, Inc.'s most recent federal award?

Gentibio, Inc.'s most recent federal grant award is Gnti-148: an allogeneic islet-specific engineered treg for treating T1D - abstract type 1 diabetes (T1D) is a chronic… (R44DK148168), from National Institute of Diabetes and Digestive and Kidney Diseases, on August 24, 2026.

On GovTribe

See Gentibio, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login